ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 1-Iodobutane Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-2H17719
Home | Market Reports | Business & Industrial| Chemicals Industry
Global 1 Iodobutane Market Research Report 2024
BUY CHAPTERS

Global 1-Iodobutane Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-2H17719
Report
October 2025
Pages:170
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SENFEIDA
Yongjin Group
Amitychem
DIDEU
Gihi Chemicals
Dayang chem (Hangzhou)
Xinhu Chemical
Nippoh Chemicals
Deepwater Chemicals
Infinium Pharmachem
Dynarx

1-Iodobutane Market

The global 1-Iodobutane market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
1-Iodobutane leading manufacturers including Senfeida, Dynarx, Yongjin Group, Amitychem, Dideu, Gihi Chemicals, Dayang Chem (Hangzhou), Xinhu Chemical, Nippoh Chemicals, Deepwater Chemicals, etc., dominate supply; the top five capture approximately % of global revenue, with Senfeida leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global 1-Iodobutane market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of 1-Iodobutane Market Report

Report Metric Details
Report Name 1-Iodobutane Market
Segment by Type
  • Purity Below 98%
  • Purity Above 98%
Segment by Application
  • Pharmaceutical
  • Chemical
  • Electronics
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Senfeida, Dynarx, Yongjin Group, Amitychem, Dideu, Gihi Chemicals, Dayang Chem (Hangzhou), Xinhu Chemical, Nippoh Chemicals, Deepwater Chemicals, Infinium Pharmachem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the 1-Iodobutane study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the 1-Iodobutane Market report?

Ans: The main players in the 1-Iodobutane Market are Senfeida, Dynarx, Yongjin Group, Amitychem, Dideu, Gihi Chemicals, Dayang Chem (Hangzhou), Xinhu Chemical, Nippoh Chemicals, Deepwater Chemicals, Infinium Pharmachem

What are the Application segmentation covered in the 1-Iodobutane Market report?

Ans: The Applications covered in the 1-Iodobutane Market report are Pharmaceutical, Chemical, Electronics, Others

What are the Type segmentation covered in the 1-Iodobutane Market report?

Ans: The Types covered in the 1-Iodobutane Market report are Purity Below 98%, Purity Above 98%

1 Study Coverage
1.1 Introduction to 1-Iodobutane: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global 1-Iodobutane Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity Below 98%
1.2.3 Purity Above 98%
1.3 Market Segmentation by Application
1.3.1 Global 1-Iodobutane Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Chemical
1.3.4 Electronics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global 1-Iodobutane Revenue Estimates and Forecasts 2020-2031
2.2 Global 1-Iodobutane Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global 1-Iodobutane Sales Estimates and Forecasts 2020-2031
2.4 Global 1-Iodobutane Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global 1-Iodobutane Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global 1-Iodobutane Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global 1-Iodobutane Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity Below 98% Market Size by Manufacturers
4.5.2 Purity Above 98% Market Size by Manufacturers
4.6 Global 1-Iodobutane Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global 1-Iodobutane Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global 1-Iodobutane Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global 1-Iodobutane Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global 1-Iodobutane Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America 1-Iodobutane Sales and Revenue by Type (2020-2031)
7.4 North America 1-Iodobutane Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America 1-Iodobutane Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe 1-Iodobutane Sales and Revenue by Type (2020-2031)
8.4 Europe 1-Iodobutane Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe 1-Iodobutane Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific 1-Iodobutane Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific 1-Iodobutane Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific 1-Iodobutane Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America 1-Iodobutane Sales and Revenue by Type (2020-2031)
10.4 Central and South America 1-Iodobutane Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America 1-Iodobutane Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa 1-Iodobutane Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa 1-Iodobutane Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa 1-Iodobutane Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Senfeida
12.1.1 Senfeida Corporation Information
12.1.2 Senfeida Business Overview
12.1.3 Senfeida 1-Iodobutane Product Models, Descriptions and Specifications
12.1.4 Senfeida 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Senfeida 1-Iodobutane Sales by Product in 2024
12.1.6 Senfeida 1-Iodobutane Sales by Application in 2024
12.1.7 Senfeida 1-Iodobutane Sales by Geographic Area in 2024
12.1.8 Senfeida 1-Iodobutane SWOT Analysis
12.1.9 Senfeida Recent Developments
12.2 Dynarx
12.2.1 Dynarx Corporation Information
12.2.2 Dynarx Business Overview
12.2.3 Dynarx 1-Iodobutane Product Models, Descriptions and Specifications
12.2.4 Dynarx 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Dynarx 1-Iodobutane Sales by Product in 2024
12.2.6 Dynarx 1-Iodobutane Sales by Application in 2024
12.2.7 Dynarx 1-Iodobutane Sales by Geographic Area in 2024
12.2.8 Dynarx 1-Iodobutane SWOT Analysis
12.2.9 Dynarx Recent Developments
12.3 Yongjin Group
12.3.1 Yongjin Group Corporation Information
12.3.2 Yongjin Group Business Overview
12.3.3 Yongjin Group 1-Iodobutane Product Models, Descriptions and Specifications
12.3.4 Yongjin Group 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Yongjin Group 1-Iodobutane Sales by Product in 2024
12.3.6 Yongjin Group 1-Iodobutane Sales by Application in 2024
12.3.7 Yongjin Group 1-Iodobutane Sales by Geographic Area in 2024
12.3.8 Yongjin Group 1-Iodobutane SWOT Analysis
12.3.9 Yongjin Group Recent Developments
12.4 Amitychem
12.4.1 Amitychem Corporation Information
12.4.2 Amitychem Business Overview
12.4.3 Amitychem 1-Iodobutane Product Models, Descriptions and Specifications
12.4.4 Amitychem 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Amitychem 1-Iodobutane Sales by Product in 2024
12.4.6 Amitychem 1-Iodobutane Sales by Application in 2024
12.4.7 Amitychem 1-Iodobutane Sales by Geographic Area in 2024
12.4.8 Amitychem 1-Iodobutane SWOT Analysis
12.4.9 Amitychem Recent Developments
12.5 Dideu
12.5.1 Dideu Corporation Information
12.5.2 Dideu Business Overview
12.5.3 Dideu 1-Iodobutane Product Models, Descriptions and Specifications
12.5.4 Dideu 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Dideu 1-Iodobutane Sales by Product in 2024
12.5.6 Dideu 1-Iodobutane Sales by Application in 2024
12.5.7 Dideu 1-Iodobutane Sales by Geographic Area in 2024
12.5.8 Dideu 1-Iodobutane SWOT Analysis
12.5.9 Dideu Recent Developments
12.6 Gihi Chemicals
12.6.1 Gihi Chemicals Corporation Information
12.6.2 Gihi Chemicals Business Overview
12.6.3 Gihi Chemicals 1-Iodobutane Product Models, Descriptions and Specifications
12.6.4 Gihi Chemicals 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Gihi Chemicals Recent Developments
12.7 Dayang Chem (Hangzhou)
12.7.1 Dayang Chem (Hangzhou) Corporation Information
12.7.2 Dayang Chem (Hangzhou) Business Overview
12.7.3 Dayang Chem (Hangzhou) 1-Iodobutane Product Models, Descriptions and Specifications
12.7.4 Dayang Chem (Hangzhou) 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Dayang Chem (Hangzhou) Recent Developments
12.8 Xinhu Chemical
12.8.1 Xinhu Chemical Corporation Information
12.8.2 Xinhu Chemical Business Overview
12.8.3 Xinhu Chemical 1-Iodobutane Product Models, Descriptions and Specifications
12.8.4 Xinhu Chemical 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Xinhu Chemical Recent Developments
12.9 Nippoh Chemicals
12.9.1 Nippoh Chemicals Corporation Information
12.9.2 Nippoh Chemicals Business Overview
12.9.3 Nippoh Chemicals 1-Iodobutane Product Models, Descriptions and Specifications
12.9.4 Nippoh Chemicals 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Nippoh Chemicals Recent Developments
12.10 Deepwater Chemicals
12.10.1 Deepwater Chemicals Corporation Information
12.10.2 Deepwater Chemicals Business Overview
12.10.3 Deepwater Chemicals 1-Iodobutane Product Models, Descriptions and Specifications
12.10.4 Deepwater Chemicals 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Deepwater Chemicals Recent Developments
12.11 Infinium Pharmachem
12.11.1 Infinium Pharmachem Corporation Information
12.11.2 Infinium Pharmachem Business Overview
12.11.3 Infinium Pharmachem 1-Iodobutane Product Models, Descriptions and Specifications
12.11.4 Infinium Pharmachem 1-Iodobutane Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Infinium Pharmachem Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 1-Iodobutane Industry Chain
13.2 1-Iodobutane Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 1-Iodobutane Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 1-Iodobutane Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 1-Iodobutane Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global 1-Iodobutane Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
SENFEIDA
Yongjin Group
Amitychem
DIDEU
Gihi Chemicals
Dayang chem (Hangzhou)
Xinhu Chemical
Nippoh Chemicals
Deepwater Chemicals
Infinium Pharmachem
Dynarx
List of Tables
 Table 1. Global 1-Iodobutane Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global 1-Iodobutane Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global 1-Iodobutane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global 1-Iodobutane Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global 1-Iodobutane Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global 1-Iodobutane Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global 1-Iodobutane Sales by Region (2020-2025) & (Tons)
 Table 8. Global 1-Iodobutane Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global 1-Iodobutane Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global 1-Iodobutane Production by Region (2020-2025) & (Tons)
 Table 12. Global 1-Iodobutane Production by Region (2026-2031) & (Tons)
 Table 13. Global 1-Iodobutane Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global 1-Iodobutane Sales Share by Manufacturers (2020-2025)
 Table 15. Global 1-Iodobutane Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global 1-Iodobutane Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global 1-Iodobutane by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1-Iodobutane as of 2024)
 Table 19. Global 1-Iodobutane Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global 1-Iodobutane Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers 1-Iodobutane Manufacturing Base and Headquarters
 Table 22. Global 1-Iodobutane Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global 1-Iodobutane Sales by Type (2020-2025) & (Tons)
 Table 26. Global 1-Iodobutane Sales by Type (2026-2031) & (Tons)
 Table 27. Global 1-Iodobutane Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global 1-Iodobutane Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global 1-Iodobutane ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global 1-Iodobutane Sales by Application (2020-2025) & (Tons)
 Table 32. Global 1-Iodobutane Sales by Application (2026-2031) & (Tons)
 Table 33. 1-Iodobutane High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global 1-Iodobutane Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global 1-Iodobutane Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global 1-Iodobutane ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America 1-Iodobutane Growth Accelerators and Market Barriers
 Table 40. North America 1-Iodobutane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America 1-Iodobutane Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe 1-Iodobutane Growth Accelerators and Market Barriers
 Table 43. Europe 1-Iodobutane Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe 1-Iodobutane Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific 1-Iodobutane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific 1-Iodobutane Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific 1-Iodobutane Growth Accelerators and Market Barriers
 Table 48. Southeast Asia 1-Iodobutane Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America 1-Iodobutane Investment Opportunities and Key Challenges
 Table 50. Central and South America 1-Iodobutane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa 1-Iodobutane Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa 1-Iodobutane Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Senfeida Corporation Information
 Table 54. Senfeida Description and Major Businesses
 Table 55. Senfeida Product Models, Descriptions and Specifications
 Table 56. Senfeida Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Senfeida Sales Value Proportion by Product in 2024
 Table 58. Senfeida Sales Value Proportion by Application in 2024
 Table 59. Senfeida Sales Value Proportion by Geographic Area in 2024
 Table 60. Senfeida 1-Iodobutane SWOT Analysis
 Table 61. Senfeida Recent Developments
 Table 62. Dynarx Corporation Information
 Table 63. Dynarx Description and Major Businesses
 Table 64. Dynarx Product Models, Descriptions and Specifications
 Table 65. Dynarx Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Dynarx Sales Value Proportion by Product in 2024
 Table 67. Dynarx Sales Value Proportion by Application in 2024
 Table 68. Dynarx Sales Value Proportion by Geographic Area in 2024
 Table 69. Dynarx 1-Iodobutane SWOT Analysis
 Table 70. Dynarx Recent Developments
 Table 71. Yongjin Group Corporation Information
 Table 72. Yongjin Group Description and Major Businesses
 Table 73. Yongjin Group Product Models, Descriptions and Specifications
 Table 74. Yongjin Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Yongjin Group Sales Value Proportion by Product in 2024
 Table 76. Yongjin Group Sales Value Proportion by Application in 2024
 Table 77. Yongjin Group Sales Value Proportion by Geographic Area in 2024
 Table 78. Yongjin Group 1-Iodobutane SWOT Analysis
 Table 79. Yongjin Group Recent Developments
 Table 80. Amitychem Corporation Information
 Table 81. Amitychem Description and Major Businesses
 Table 82. Amitychem Product Models, Descriptions and Specifications
 Table 83. Amitychem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Amitychem Sales Value Proportion by Product in 2024
 Table 85. Amitychem Sales Value Proportion by Application in 2024
 Table 86. Amitychem Sales Value Proportion by Geographic Area in 2024
 Table 87. Amitychem 1-Iodobutane SWOT Analysis
 Table 88. Amitychem Recent Developments
 Table 89. Dideu Corporation Information
 Table 90. Dideu Description and Major Businesses
 Table 91. Dideu Product Models, Descriptions and Specifications
 Table 92. Dideu Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Dideu Sales Value Proportion by Product in 2024
 Table 94. Dideu Sales Value Proportion by Application in 2024
 Table 95. Dideu Sales Value Proportion by Geographic Area in 2024
 Table 96. Dideu 1-Iodobutane SWOT Analysis
 Table 97. Dideu Recent Developments
 Table 98. Gihi Chemicals Corporation Information
 Table 99. Gihi Chemicals Description and Major Businesses
 Table 100. Gihi Chemicals Product Models, Descriptions and Specifications
 Table 101. Gihi Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Gihi Chemicals Recent Developments
 Table 103. Dayang Chem (Hangzhou) Corporation Information
 Table 104. Dayang Chem (Hangzhou) Description and Major Businesses
 Table 105. Dayang Chem (Hangzhou) Product Models, Descriptions and Specifications
 Table 106. Dayang Chem (Hangzhou) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Dayang Chem (Hangzhou) Recent Developments
 Table 108. Xinhu Chemical Corporation Information
 Table 109. Xinhu Chemical Description and Major Businesses
 Table 110. Xinhu Chemical Product Models, Descriptions and Specifications
 Table 111. Xinhu Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Xinhu Chemical Recent Developments
 Table 113. Nippoh Chemicals Corporation Information
 Table 114. Nippoh Chemicals Description and Major Businesses
 Table 115. Nippoh Chemicals Product Models, Descriptions and Specifications
 Table 116. Nippoh Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Nippoh Chemicals Recent Developments
 Table 118. Deepwater Chemicals Corporation Information
 Table 119. Deepwater Chemicals Description and Major Businesses
 Table 120. Deepwater Chemicals Product Models, Descriptions and Specifications
 Table 121. Deepwater Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. Deepwater Chemicals Recent Developments
 Table 123. Infinium Pharmachem Corporation Information
 Table 124. Infinium Pharmachem Description and Major Businesses
 Table 125. Infinium Pharmachem Product Models, Descriptions and Specifications
 Table 126. Infinium Pharmachem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. Infinium Pharmachem Recent Developments
 Table 128. Key Raw Materials Distribution
 Table 129. Raw Materials Key Suppliers
 Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 131. Milestones in Production Technology Evolution
 Table 132. Distributors List
 Table 133. Market Trends and Market Evolution
 Table 134. Market Drivers and Opportunities
 Table 135. Market Challenges, Risks, and Restraints
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources


List of Figures
 Figure 1. 1-Iodobutane Product Picture
 Figure 2. Global 1-Iodobutane Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purity Below 98% Product Picture
 Figure 4. Purity Above 98% Product Picture
 Figure 5. Global 1-Iodobutane Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pharmaceutical
 Figure 7. Chemical
 Figure 8. Electronics
 Figure 9. Others
 Figure 10. 1-Iodobutane Report Years Considered
 Figure 11. Global 1-Iodobutane Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 13. Global 1-Iodobutane Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global 1-Iodobutane Revenue Market Share by Region (2020-2031)
 Figure 15. Global 1-Iodobutane Sales (2020-2031) & (Tons)
 Figure 16. Global 1-Iodobutane Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global 1-Iodobutane Sales Market Share by Region (2020-2031)
 Figure 18. Global 1-Iodobutane Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global 1-Iodobutane Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global 1-Iodobutane Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. 1-Iodobutane Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. 1-Iodobutane Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. 1-Iodobutane Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. 1-Iodobutane Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 26. Top 5 and Top 10 Manufacturers 1-Iodobutane Sales Volume Market Share in 2024
 Figure 27. Global 1-Iodobutane Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. Purity Below 98% Revenue Market Share by Manufacturer in 2024
 Figure 30. Purity Above 98% Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global 1-Iodobutane Sales Market Share by Type (2020-2031)
 Figure 34. Global 1-Iodobutane Revenue Market Share by Type (2020-2031)
 Figure 35. Global 1-Iodobutane Sales Market Share by Application (2020-2031)
 Figure 36. Global 1-Iodobutane Revenue Market Share by Application (2020-2031)
 Figure 37. North America 1-Iodobutane Sales YoY (2020-2031) & (Tons)
 Figure 38. North America 1-Iodobutane Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers 1-Iodobutane Sales Revenue (US$ Million) in 2024
 Figure 40. North America 1-Iodobutane Sales Volume (Tons) by Type (2020- 2031)
 Figure 41. North America 1-Iodobutane Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America 1-Iodobutane Sales Volume (Tons) by Application (2020-2031)
 Figure 43. North America 1-Iodobutane Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe 1-Iodobutane Sales YoY (2020-2031) & (Tons)
 Figure 48. Europe 1-Iodobutane Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers 1-Iodobutane Sales Revenue (US$ Million) in 2024
 Figure 50. Europe 1-Iodobutane Sales Volume (Tons) by Type (2020-2031)
 Figure 51. Europe 1-Iodobutane Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe 1-Iodobutane Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Europe 1-Iodobutane Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 55. France 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific 1-Iodobutane Sales YoY (2020-2031) & (Tons)
 Figure 60. Asia-Pacific 1-Iodobutane Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers 1-Iodobutane Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific 1-Iodobutane Sales Volume (Tons) by Type (2020- 2031)
 Figure 63. Asia-Pacific 1-Iodobutane Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific 1-Iodobutane Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Asia-Pacific 1-Iodobutane Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 70. India 1-Iodobutane Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America 1-Iodobutane Sales YoY (2020-2031) & (Tons)
 Figure 72. Central and South America 1-Iodobutane Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers 1-Iodobutane Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America 1-Iodobutane Sales Volume (Tons) by Type (2021-2031)
 Figure 75. Central and South America 1-Iodobutane Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America 1-Iodobutane Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Central and South America 1-Iodobutane Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil 1-Iodobutane Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina 1-Iodobutane Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa 1-Iodobutane Sales YoY (2020-2031) & (Tons)
 Figure 81. Middle East and Africa 1-Iodobutane Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers 1-Iodobutane Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa 1-Iodobutane Sales Volume (Tons) by Type (2021-2031)
 Figure 84. South America 1-Iodobutane Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa 1-Iodobutane Sales Volume (Tons) by Application (2020-2031)
 Figure 86. Middle East and Africa 1-Iodobutane Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries 1-Iodobutane Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey 1-Iodobutane Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt 1-Iodobutane Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa 1-Iodobutane Revenue (2020-2025) & (US$ Million)
 Figure 91. 1-Iodobutane Industry Chain Mapping
 Figure 92. Regional 1-Iodobutane Manufacturing Base Distribution (%)
 Figure 93. 1-Iodobutane Production Process
 Figure 94. Regional 1-Iodobutane Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global 1 Bromobutane Market Research Report 2025
Global 4 Iodobutanoic Acid Market Research Report 2025
Global 1 3 Dihydroxybutane Market Research Report 2025
Global 1 3 Dimethoxybutane Market Research Report 2024
Global Iodinated Oil Market Research Report 2025
Global 1 1 1 3 3 Pentafluorobutane Market Research Report 2025
Global Butyl Isobutyrate Market Research Report 2025
Global High Purity Isobutane Market Research Report 2025
Global Iodine Radioisotope Market Research Report 2024
Global Isobutyric Acid Market Research Report 2024
Global 1 Bromodecane Market Research Report 2024
Global Isobutylene Market Research Report 2025
Global Isobutyramide Market Research Report 2025
Global Isobutyl Formate Market Research Report 2025
Global Diisobutyl Ketone Market Research Report 2025
Global 1 Bromo 3 Methyl Butane Market Research Report 2024
Global Iohexyl Iodide Market Research Report 2024
Global Isobutyl Isobutyrate IBIB Market Research Report 2024
Global 1 3 Butadiene BD Market Research Report 2025
Global Tetrabutyl Titanate Market Research Report 2025

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions